Career Development Program
Career Development Program
批准号:
8932167
负责人:
KEVIN M. SHANNON
金额:
$10.45万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2020-08-31
关键词:
AddressAreaBasic ScienceBudgetsCaliforniaCancer BiologyChildhoodCitiesClinicalClinical SciencesDataDevelopmentDevelopment PlansDisadvantagedDisciplineExtramural ActivitiesFacultyFundingGoalsHumanIndianaIndividualInstitutionKnowledgeLesbian Gay BisexualLinkMalignant NeoplasmsMedical centerMentorsMissionMutationNF1 geneNational Cancer InstituteNatureNorth CarolinaPediatric HospitalsPennsylvaniaPhiladelphiaPopulationProcessRecruitment ActivityReproduction sporesResearchResearch PersonnelResearch Project GrantsResourcesSan FranciscoScheduleScientistSignal TransductionStructureTexasTextilesTherapeuticTrainingTranslational ResearchUnderrepresented MinorityUniversitiesWomanWorkabstractinganticancer researchcancer therapycareercareer developmentethnic minority populationinnovationmeetingsmemberprofessorprogramsskillssuccesstransgendertumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – CAREER DEVELOPMENT PROGRAM
The Developmental Hyperactive Ras Tumor (DHART) SPORE Career Development Program (CDP) will
support faculty at the Assistant Professor level to engage in translational research focused on NF1 and cancer.
The specific purpose or the CDP is to advance the careers of junior investigators who are developing
innovative research projects related to the goal of implementing more effective and less toxic therapies for
cancers characterized by NF1 mutations. The DHART SPORE also includes a Developmental Research
Program (DRP), which has the complementary mission of funding established investigators who seek to
develop new research related to NF1-related cancers and is presented in a separate section of this application.
The multi-institutional nature of this SPORE leverages a large and talented pool of junior faculty from multiple
disciplines. Each institution views the CDP as a vehicle for recruiting, training, and advancing young scientists
working in the area of translational cancer research related to NF1, and they have committed $1.3 million to
support the Developmental Programs component of the DHART SPORE (DRP and CDP). The Specific Aims
of the CDP are: (1) to support new investigators as they develop innovative research programs with the goal of
contributing new knowledge to the field of NF1-related cancer research while generating preliminary data that
will allow them to successfully apply for independent extramural funding; (2) to provide young researchers with
didactic training that will equip them with essential skills and knowledge for success as an independent
investigator in the field of NF1-related cancer research; (3) to mentor young translational researchers through
regularly scheduled one-on-one meetings with a designated senior faculty member and a structured Individual
Career Development Plan (IDP) who will fully integrate the CDP-supported investigator into the fabric of the
DHART SPORE where they have access to advice, resources, and potential collaborators; and, (4) to
encourage the recruitment of ethnic minorities, those from disadvantaged backgrounds, women and
lesbian/gay/bisexual/transgender (LGBT) populations into research focused on NF1-associated cancers. The
DHART SPORE will link vertically and horizontally to diversity programs at all of the consortium institutions.
Investigators from any of these centers can apply for CDP funds, and we will also consider proposals from
researchers at other institutions. The CDP will fund a minimum of two projects per year at an annual budget of
$50,000 - $75,000. Applications for CDP support (including requests for a second year of funding) will be
evaluated through a competitive process with review by a Developmental Programs Steering Committee
comprised on senor scientists participating in this SPORE and oversight and guidance from the External and
Internal Advisory Boards.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies
-
批准号:9924474
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2017
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:10372214
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
-
批准号:8932164
-
项目类别:
-
资助金额:$43.13万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:10209682
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Developmental Research Program
-
批准号:8932166
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:9040123
-
项目类别:
-
资助金额:$55.05万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:10610346
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Career Enhancement Program
-
批准号:10494113
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Developmental Research Program
-
批准号:10494111
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
-
批准号:10270583
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
-
批准号:10494109
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:9278130
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Developmental Research Program
-
批准号:10270584
-
项目类别:
-
资助金额:$9.02万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Career Enhancement Program
-
批准号:10270585
-
项目类别:
-
资助金额:$9.02万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:8895286
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:9112921
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:8590462
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:8735906
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
ID OF MOLECULES THAT SUBSTITUTE FOR ACTIVE NOTCH1 IN T LINEAGE LEUKEMOGENESIS
-
批准号:8363842
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2011
-
负责人:KEVIN M. SHANNON
-
依托单位:
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22
-
批准号:8319537
-
项目类别:
-
资助金额:$43.4万
-
财政年份:2011
-
负责人:KEVIN M. SHANNON
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: